英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：

photom    
n. 光子

光子


请选择你想看的字典辞典：
单词字典翻译
Photom查看　Photom　在百度字典中的解释百度英翻中〔查看〕
Photom查看　Photom　在Google字典中的解释Google英翻中〔查看〕
Photom查看　Photom　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Pfizer, BioNTech halt US COVID vaccine study after recruitment . . . - MSN
    Vaccine makers Pfizer PFE N and BioNTech 22UAy DE halted a large U S trial of their updated COVID-19 vaccine in healthy adults aged 50 to 64, saying enrollment in the trials had been too low to
  • Exclusive: Pfizer, BioNTech halt US COVID vaccine study after . . .
    Vaccine makers Pfizer and BioNTech halted a large U S trial of their updated COVID-19 vaccine in healthy adults aged 50 to 64, saying enrollment in the trials had been too low to generate the
  • Pfizer, BioNTech halt US COVID vaccine study after recruitment struggles
    Pfizer and BioNTech have halted their U S COVID-19 vaccine trial for adults aged 50-64 due to low enrollment numbers The companies faced difficulties in meeting FDA requirements for large trials, leading to the suspension of recruitment and study monitoring Learn more about the implications of this decision on vaccine approvals
  • Pfizer, BioNTech halt US COVID vaccine study after recruitment . . .
    Vaccine makers Pfizer and BioNTech halted a large U S trial of their updated COVID-19 vaccine in healthy adults aged 50 to 64, saying enrollment in the trials had been too low to generate the
  • Pfizer and BioNTech Hit the Brakes on a Key COVID Vaccine Trial
    Key Points Pfizer and BioNTech have halted recruitment for a large U S trial of their updated COVID-19 vaccine for adults aged 50 to 64, citing insufficient enrollment The decision reflects broader challenges, including tighter FDA requirements for approval in this age group and declining public interest in boosters In a separate but significant development, Pfizer won a legal case in
  • Exclusive: Pfizer, BioNTech Halt US COVID Vaccine Study After . . .
    By The Defender Staff Exclusive: Pfizer, BioNTech Halt US COVID Vaccine Study After Recruitment Struggles U S News World Report reported: Vaccine makers Pfizer and BioNTech halted a large U S trial of ⁠their ⁠updated COVID-19 vaccine in healthy adults aged 50 to 64, ⁠saying enrollment in the trials had been too low to generate the needed data In a letter to trial investigators dated
  • Pfizer, BioNTech halt US trial of COVID-19 vaccine over low enrollment
    Pfizer and BioNTech have halted a major U S clinical trial of their updated COVID-19 vaccine in adults aged 50 to 64, citing insufficient participant enrollment to produce reliable data In a March 30 letter to investigators, seen by Reuters, Pfizer said it would stop monitoring participants for COVID-19 illness after April 3, effectively ending the study’s active surveillance phase
  • Pfizer and BioNTech halt U. S. COVID-19 vaccine study after recruitment . . .
    Vaccine makers Pfizer and BioNTech halted a large U S trial of their updated COVID-19 vaccine in healthy adults aged 50 to 64, saying enrollment in the trials had been too low to generate the
  • Exclusive-Pfizer, BioNTech halt US COVID vaccine study after . . .
    By Bhanvi Satija LONDON, April 1 (Reuters) – Vaccine makers Pfizer and BioNTech halted a large U S trial of their updated COVID-19 vaccine in healthy adults aged 50 to 64, saying enrollment in the trials had been too low to generate the needed data In a letter to trial investigators dated March 30, seen by Reuters and previously unreported, Pfizer said it would stop surveillance for signs
  • Pfizer and BioNTech Halt COVID Vaccine Trial Recruitment
    Trial Recruitment Halted: Pfizer and BioNTech have suspended recruitment for their COVID-19 vaccine clinical trial targeting healthy adults aged 50-64 due to insufficient enrollment, originally aiming for 25,000 to 30,000 participants, highlighting significant challenges in vaccine research Regulatory Communication: The companies communicated with the FDA regarding their plans to halt the





中文字典-英文字典  2005-2009